"Foundayo is the first GLP-1 pill that can be taken at any time of day, regardless of meals, providing a significant convenience for patients."
"Adam Salberg, a participant in the clinical trial, expressed satisfaction with the ease of incorporating Foundayo into his existing medication regimen, stating, 'It was just very simple to add it.'"
Eli Lilly's Foundayo, a once-daily GLP-1 pill for weight loss, received FDA approval, marking a significant advancement in diabetes and weight loss treatment. Unlike previous GLP-1 medications that required injections or specific timing, Foundayo offers convenience as it can be taken at any time of day. Adam Salberg, a participant in a clinical trial, reported positive experiences with the medication, noting reduced hunger and easier integration into his daily routine. This approval opens up access to millions of patients seeking effective weight management solutions.
Read at www.businessinsider.com
Unable to calculate read time
Collection
[
|
...
]